Emergent BioSolutions
EBS
#8133
Rank
NZ$0.64 B
Marketcap
NZ$12.58
Share price
3.67%
Change (1 day)
-20.62%
Change (1 year)

Emergent BioSolutions (EBS) - Net assets

Net assets on the balance sheet as of June 2026 : NZ$0.60 Billion

According to Emergent BioSolutions 's latest financial reports the company has NZ$0.60 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Emergent BioSolutions - Net assets on balance sheet (from 2004 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$NZ$0.90 B5.41%
2024-12-31$NZ$0.85 B-16.62%
2023-12-31$NZ$1.02 B-53.03%
2022-12-31$NZ$2.18 B-7.36%
2021-12-31$NZ$2.35 B17.65%
2020-12-31$NZ$2.00 B24.08%
2019-12-31$NZ$1.61 B7.24%
2018-12-31$NZ$1.50 B17.32%
2017-12-31$NZ$1.28 B49.24%
2016-12-31$NZ$0.86 B-10.75%
2015-12-31$NZ$0.96 B36.58%
2014-12-31$NZ$0.70 B18.61%
2013-12-31$NZ$0.59 B10.76%
2012-12-31$NZ$0.53 B0.66%
2011-12-31$NZ$0.53 B10.27%
2010-12-31$NZ$0.48 B44.25%
2009-12-31$NZ$0.33 B-2.28%
2008-12-31$NZ$0.34 B53.74%
2007-12-31$NZ$0.22 B13.68%
2006-12-31$NZ$0.19 B124.89%
2005-12-31$NZ$87.39 M171.75%
2004-12-31$NZ$32.16 M
2002-12-31$NZ$7.93 M-110.21%
2001-12-31$-NZ$77.78 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
NZ$152.33 B 24,941.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$74.81 B 12,197.60%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$40.55 B 6,566.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
NZ$5.5 M-99.09%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.29 B-51.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$1.27 B 109.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$13.82 B 2,172.11%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel